Evidence map›Paper›PMID 33781051›Full record

ArticleCancer research and treatment2022

The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11).

Joo Ho Lee, Seung Hyuck Jeon, Chul-Kee Park, Sung-Hye Park, Hong In Yoon, Jong Hee Chang, Chang-Ok Suh, Su Jeong Kang, Do Hoon Lim, In Ah Kim and 5 more

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Cancer research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Joo Ho LeeDepartment of Radiation Oncology, Seoul National University Hospital, Seoul National University, College of Medicine, Seoul, Korea.
Seung Hyuck JeonDepartment of Radiation Oncology, Seoul National University Hospital, Seoul National University, College of Medicine, Seoul, Korea.
Chul-Kee ParkDepartment of Neurosurgery, Seoul National University Hospital, Seoul, Korea.
Sung-Hye ParkDepartment of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Hong In YoonDepartment of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea.
Jong Hee ChangDepartment of Neurosurgery, Severance Hospital, Yonsei University Health System, Seoul, Korea.
Chang-Ok SuhDepartment of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea.
Su Jeong KangDepartment of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Do Hoon LimDepartment of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
In Ah KimDepartment of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Korea.
Jin Hee KimDepartment of Radiation Oncology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.
Jung Ho ImDepartment of Radiation Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Sung-Hwan KimDepartment of Radiation Oncology, St. Vincent's Hospital, Suwon, Korea.
Chan Woo WeeDepartment of Radiation Oncology, SMG-SNU Boramae Medical Center, Seoul, Korea.
Il Han KimDepartment of Radiation Oncology, Seoul National University Hospital, Seoul National University, College of Medicine, Seoul, Korea.
Seoul National University Hospital · KRYonsei University Health System · KRCHA University · KRCHA University Bundang Medical Center · KRKeimyung University · KRSamsung Medical Center · KRSeoul National University · KRSeoul National University Bundang Hospital · KRSNUH SMG-SNU Boramae Medical Center · KRSungkyunkwan University · KRThe Catholic University of Korea St. Vincent's Hospital · KR

Funding

Ministry of Education, Science and TechnologyNational Research Foundation of Korea 2018R1D1A1A02085487National Research Foundation of Korea 2020M2D9A2092373Seoul National University Hospital 04-2019-0830
6 · The paper itself

Abstract

purposeThis study aimed to evaluate the role of postoperative radiotherapy (PORT) in intracranial solitary fibrous tumor/hemangiopericytoma (SFT/HPC). MATERIALS AND

methodsA total of 133 patients with histologically confirmed HPC were included from eight institutions. Gross total resection (GTR) and subtotal resection (STR) were performed in 86 and 47 patients, respectively. PORT was performed in 85 patients (64%). The prognostic effects of sex, age, performance, World Health Organization (WHO) grade, location, size, Ki-67, surgical extent, and PORT on local control (LC), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) were estimated by univariate and multivariate analyses.

resultsThe 10-year PFS, and OS rates were 45%, and 71%, respectively. The multivariate analysis suggested that PORT significantly improved LC (p < 0.001) and PFS (p < 0.001). The PFS benefit of PORT was maintained in the subgroup of GTR (p=0.001), WHO grade II (p=0.001), or STR (p < 0.001). In the favorable subgroup of GTR and WHO grade II, PORT was also significantly related to better PFS (p=0.028). WHO grade III was significantly associated with poor DMFS (p=0.029). In the PORT subgroup, the 0-0.5 cm margin of the target volume showed an inferior LC to a large margin with 1.0-2.0 cm (p=0.021). Time-dependent Cox proportion analysis showed that distant failures were significantly associated with poor OS (p=0.003).

conclusionThis multicenter study supports the role of PORT in disease control of intracranial SFT/HPC, irrespective of the surgical extent and grade. For LC, PORT should enclose the tumor bed with sufficient margin.

Indexed as

AdolescentAdultAgedBrain NeoplasmsChildDisease-Free SurvivalFemaleHemangiopericytomaHumansMaleMiddle AgedPostoperative CareProgression-Free SurvivalRetrospective StudiesSolitary Fibrous TumorsHemangiopericytomaIntracranialMarginPostoperativeRadiotherapySolitary fibrous tumor

Identifiers

PMID33781051
PMCPMC8756112
OpenAlexW3137932362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.